Company intelligence / Profile preview

GoSilico

Karlsruhe, Baden-Württemberg, Germany

Ownership: Private
Development stage: Other

Overview

GoSilico does not develop therapeutics; it provides commercial mechanistic modeling and digital twin software (ChromX/DSPX) and related services to support development, scale-up, and tech transfer of biopharmaceutical downstream processes, especially chromatography.[1][4][5]

Modalities: Non-pharmacological therapy
Industry: Drug Discovery Services

Partnerships

Integration with Cytiva ÄKTA chromatography systems and UNICORN software[6][7]

Beyond the preview

Go deeper on GoSilico.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GoSilico.

Explore the full profile